BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 19404873)

  • 1. Recent progress and diverse effects in developmental immunotoxicology: overview of a symposium at the 46th Annual SOT Meeting, Charlotte, NC.
    Rooney AA; Yang Y; Makris SL
    J Immunotoxicol; 2008 Oct; 5(4):395-400. PubMed ID: 19404873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental immunotoxicology (DIT): windows of vulnerability, immune dysfunction and safety assessment.
    Dietert RR
    J Immunotoxicol; 2008 Oct; 5(4):401-12. PubMed ID: 19404874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental immunotoxicology: focus on health risks.
    Dietert RR
    Chem Res Toxicol; 2009 Jan; 22(1):17-23. PubMed ID: 18783253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmental immunotoxicity (DIT) in drug safety testing: matching DIT testing to adverse outcomes and childhood disease risk.
    Dietert RR
    Curr Drug Saf; 2008 Sep; 3(3):216-26. PubMed ID: 18691005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential for early-life immune insult including developmental immunotoxicity in autism and autism spectrum disorders: focus on critical windows of immune vulnerability.
    Dietert RR; Dietert JM
    J Toxicol Environ Health B Crit Rev; 2008 Oct; 11(8):660-80. PubMed ID: 18821424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developmental immunotoxicity (DIT), postnatal immune dysfunction and childhood leukemia.
    Dietert RR
    Blood Cells Mol Dis; 2009; 42(2):108-12. PubMed ID: 19019708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methodologies for developmental immunotoxicity (DIT) testing.
    Dietert RR; Holsapple MP
    Methods; 2007 Jan; 41(1):123-31. PubMed ID: 17161309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal and early life stress effects on immune function: relevance to immunotoxicology.
    Bellinger DL; Lubahn C; Lorton D
    J Immunotoxicol; 2008 Oct; 5(4):419-44. PubMed ID: 19404876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early-life environment, developmental immunotoxicology, and the risk of pediatric allergic disease including asthma.
    Dietert RR; Zelikoff JT
    Birth Defects Res B Dev Reprod Toxicol; 2008 Dec; 83(6):547-60. PubMed ID: 19085948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The managed immune system: protecting the womb to delay the tomb.
    Dietert RR; Piepenbrink MS
    Hum Exp Toxicol; 2008 Feb; 27(2):129-34. PubMed ID: 18480137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What's so special about the developing immune system?
    Burns-Naas LA; Hastings KL; Ladics GS; Makris SL; Parker GA; Holsapple MP
    Int J Toxicol; 2008; 27(2):223-54. PubMed ID: 18404545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of developmental immunotoxicity and immune dysfunction in chronic disease and cancer.
    Dietert RR
    Reprod Toxicol; 2011 Apr; 31(3):319-26. PubMed ID: 20854896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developmental immunotoxicity (DIT): the why, when, and how of DIT testing.
    Dietert RR; Dewitt J
    Methods Mol Biol; 2010; 598():17-25. PubMed ID: 19967503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental immunotoxicity (DIT) testing of pharmaceuticals: current practices, state of the science, knowledge gaps, and recommendations.
    Collinge M; Burns-Naas LA; Chellman GJ; Kawabata TT; Komocsar WJ; Piccotti JR; Shenton J; Wierda D
    J Immunotoxicol; 2012; 9(2):210-30. PubMed ID: 22428536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible role for early-life immune insult including developmental immunotoxicity in chronic fatigue syndrome (CFS) or myalgic encephalomyelitis (ME).
    Dietert RR; Dietert JM
    Toxicology; 2008 May; 247(1):61-72. PubMed ID: 18336982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toxicopathology of the developing immune system: investigative and development strategies.
    Weinstock D; Lewis DB; Parker GA; Beyer J; Collinge M; Brown TP; Dybdal N
    Toxicol Pathol; 2010 Dec; 38(7):1111-7. PubMed ID: 20962107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status of developmental immunotoxicity: early-life patterns and testing.
    DeWitt JC; Peden-Adams MM; Keil DE; Dietert RR
    Toxicol Pathol; 2012; 40(2):230-6. PubMed ID: 22109713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Juvenile immunotoxicology.
    Holsapple MP; O'Lone R
    Toxicol Pathol; 2012; 40(2):248-54. PubMed ID: 22252913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approaches and considerations for the assessment of immunotoxicity for environmental chemicals: a workshop summary.
    Boverhof DR; Ladics G; Luebke B; Botham J; Corsini E; Evans E; Germolec D; Holsapple M; Loveless SE; Lu H; van der Laan JW; White KL; Yang Y
    Regul Toxicol Pharmacol; 2014 Feb; 68(1):96-107. PubMed ID: 24280359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of immune system development in nonclinical species and humans: Closing information gaps for immunotoxicity testing and human translatability.
    Skaggs H; Chellman GJ; Collinge M; Enright B; Fuller CL; Krayer J; Sivaraman L; Weinbauer GF
    Reprod Toxicol; 2019 Oct; 89():178-188. PubMed ID: 31233776
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.